awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33415893-751E133B-1818-466D-87FF-5CD41E1240CD
Q33415893-751E133B-1818-466D-87FF-5CD41E1240CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415893-751E133B-1818-466D-87FF-5CD41E1240CD
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
P2860
Q33415893-751E133B-1818-466D-87FF-5CD41E1240CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415893-751E133B-1818-466D-87FF-5CD41E1240CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcec2c9b8ff2249e981815a2613fe3a5701e091d
P2860
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma